Philip S. Boyd1, Johannes Breitling1, Ferdinand Zimmermann1, Andreas Korzowski1, Moritz Zaiss2, Kai Herz2, Patrick Schuenke1, Nina Weinfurtner3, Heinz-Peter Schlemmer3, Mark E. Ladd1, Peter Bachert1, Daniel Paech3, and Steffen Goerke1
1Division of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany, 2High‐field Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tübingen, Germany, Tübingen, Germany, 3Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Synopsis
In this study, an acquisition
protocol for glucoCESL MRI examinations in the human brain is presented, that was
optimized for suppression of motion-induced artifacts. This was achieved by
using a combination of (i) a 3D imaging readout, which enabled co-registration
of the acquired images over the course of time, and (ii) a ΔR1ρ contrast
based on quantitative R1ρ maps instead of R1ρ-weighted
images. The presented acquisition protocol improves the applicability of glucose-weighted
MRI for examinations in humans where motion is present. Feasibility was
verified by examination in a first patient with glioblastoma.
Introduction
Chemical exchange-sensitive MRI
after administration of glucose (glucoCEST/CESL) has been shown to provide insights
into glucose perfusion/uptake, which is of particular interest for the
identification of active tumor regions1. Also its applicability
for examinations in humans was already verified by two independent pilot
studies2,3. However, contrast maps are prone to motion-induced
artifacts, as the final glucoCEST/CESL contrast relies on the difference of
images which were acquired with a time gap of several tens of minutes. In this
study, identification of different types of motion-induced artifacts (spatial
displacement, spatially varying sensitivity of the coil, slab selection profile) led to the development
of a 3D acquisition protocol for glucoCESL examinations in the human brain at
7T with improved robustness against motion.
Methods
To allow a clear
identification of motion-induced artifacts one healthy volunteer was examined
without administration of glucose. In addition, a first patient (glioblastoma,
WHO grade IV) was examined with administration of D-glucose (2min,100ml,20%).
The examinations were approved by the local ethics committee.
In vivo 3D CESL MRI (1.7×1.7×3mm3,14 slices) was performed on a 7T-MR scanner
(Siemens) using the snapshot-CEST4 approach. Image readout
parameters were adapted from ref.4: 560 Hz/pix BW, Grappa 3, 6° FA.
Pre-saturation
was achieved by an adiabatically prepared spin-lock pulse that was optimized in
previous studies5,6(i.e. B$$$_1$$$=5µT, t$$$_{rec}$$$=5s).
Images with and without R$$$_{1ρ}$$$ weighting (i.e.
spin-lock time TSL=50 and 0.2ms) were acquired in an interleaved manner. Co-registration
was performed separately for the two series of images with different TSL using a
rigid registration algorithm in MITK7. The transformation
information of the co-registration was used to quantify the presence of motion. B1- and B0-maps were calculated using the WASABI-method8.
The
dynamic glucose-enhanced (DGE$$$_\rho$$$)3,6 contrast was calculated by$$$~DGE_\rho(t)=\frac{S_{50ms}(ref)\,-\,S_{50ms}(t)}{S_{50ms}(ref)\;\cdot\;50ms}~$$$[Eq.1], where S$$$_{50ms}$$$(t)
are the acquired R$$$_{1ρ}$$$-weighted images, and S$$$_{50ms}$$$(ref) is the average of the
first twenty S$$$_{50ms}$$$(t) images. The ΔR$$$_{1ρ}$$$ contrast
based on quantitative R$$$_{1ρ}$$$ maps was calculated according to Jin et
al.1:
$$$\Delta R_{1\rho}(t)=R_{1\rho}(t)-R_{1\rho}(ref)~$$$[Eq.2], with $$$R_{1\rho}(t)=\frac{\ln[S_{0.2ms}(t)/S_{50ms}(t)]}{50ms\;-\;0.2ms}~$$$[Eq.3],
and R$$$_{1ρ}$$$(ref)
being the average of the first ten R$$$_{1ρ}$$$(t) maps.
Results
The observed motion of the healthy
volunteer during the approximately 40-minute-long examination was in the range
of about ±0.5mm and ±1° in each spatial dimension (Fig.1e). Already,
such subtle spatial displacements led to strong artifacts in the time course of
the unregistered R$$$_{1ρ}$$$-weighted DGE$$$_\rho$$$ contrast (Fig.2a,b).
A significant reduction of the motion-induced artifacts was observed after co-registration (Fig.2c,d). However, a global increase in the DGE$$$_{\rho}$$$ contrast was still present throughout almost the entire brain, originating mainly
from the spatially varying sensitivity of the coil (Fig.1a). We found
that an adequate suppression of this global artifact can be achieved by
acquisition of a series of quantitative R$$$_{1ρ}$$$ maps (Fig.2e,f)
instead of R$$$_{1ρ}$$$-weighted images. The variation of the resulting ΔR$$$_{1ρ}$$$
time course was in the approximate range of the noise level (i.e.±0.25Hz) and
the center of the contrast histogram remained sufficiently constant over time (Fig.3). The final acquisition protocol, including
co-registration and quantitative R$$$_{1ρ}$$$ mapping, was then utilized to
investigate signal changes after administration of glucose in a patient with
glioblastoma. A clear signal increase after glucose injection was observed on
one side of the Gd-contrast ring-enhancement (Fig.4, white arrows),
which did not correlate with observed B$$$_0$$$-inhomogeneities (Fig.4, black arrows).
Discussion
The advantage of quantitative ΔR$$$_{1ρ}$$$ imaging is due to the ratio of two consecutively acquired R$$$_{1ρ}$$$-weighted
images (Eq.3). Assuming negligible motion during two consecutive images
(Δt$$$~$$$≈$$$~$$$7s), this division normalizes the spatially varying sensitivity of the
coil (compare Fig.1a,b) and slab selection profile, which are both dependent on the
position of the head. In contrast, glucoCEST- and DGE$$$_\rho$$$-imaging is
prone to changes in the spatially varying sensitivity of the coil or altered slab selection, as for
normalization a reference image at the beginning of the examination is always
used (Eq.1,$$$~$$$Δt$$$~$$$≈$$$~$$$up to several minutes). However, partial volume
effects can still not be compensated completely by the quantitative ΔR$$$_{1ρ}$$$ approach which is why the interpretation of the ΔR$$$_{1ρ}$$$ contrast at
sharp edges (e.g.tissue borders) has to be performed with caution. Nevertheless,
in the examination of a tumor patient in this study, no negative signals were
observed around the glucose-induced signal increase in the tumor region (Fig.4, white arrows), providing a preliminary verification of the applicability
of the presented acquisition protocol to tumor imaging.
Conclusion
The presented 3D acquisition protocol
allows glucoCESL examinations in the human brain with improved robustness
against motion-induced artifacts. Removing artifacts for glucose-weighted MRI
in humans is of high importance for future clinical trials in which an unequivocal
assignment of contrast changes to an actual glucose perfusion/uptake is a prerequisite.
A sufficient reduction of motion-induced artifacts may also allow transfer of glucose-weighted MRI to clinical magnetic field strengths (i.e.3T), where the contrast-to-noise ratio
is even lower.
Acknowledgements
The financial support for MZ and KH
of the Max Planck Society, German Research Foundation (DFG, grant ZA 814/2-1), and European Union’s Horizon 2020 research and innovation program (Grant
Agreement No. 667510) is gratefully acknowledged.
References
1. Jin T, Iordanova B, Hitchens TK,
et al. Chemical exchange–sensitive spin-lock (CESL) MRI of glucose
and analogs in brain tumors. Magn
Reson Med 2018; 80:488-495.
2. Xu X, Yadav NN, Knutsson L, et
al. Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First
Results in Glioma Patients. Tomography 2015; 1(2):105-114.
3. Paech D, Schuenke P, Koehler C,
et al. T1ρ-weighted Dynamic Glucose-enhanced MR Imaging in the Human Brain.
Radiology 2017; 285(3):914-922.
4. Zaiss M, Ehses P, and Scheffler
K. Snapshot-CEST: Optimizing spiral-centric-reordered gradient echo acquisition
for fast and robust 3D CEST MRI at 9.4 T. NMR Biomed 2018; 31:e3879.
5. Schuenke P, Koehler C, Korzowski A, et al. Adiabatically Prepared
Spin-Lock Approach for T1ρ-Based Dynamic Glucose Enhanced MRI at Ultrahigh
Fields. Magn Reson Med 2017; 78:215-225.
6. Schuenke P, Paech D, Koehler C, et al. Fast and Quantitative T1ρ-weighted Dynamic
Glucose Enhanced MRI. Scientific Reports 2017; 7: 2045-2322.
7. Nolden M, Zelzer S, Seitel A, et
al. The
Medical Imaging Interaction Toolkit: challenges and advances. Int J CARS 2013;
8(4):607-620.
8. Schuenke P, Windschuh J,
Roeloffs V, et al. Simultaneous mapping of water shift and B1(WASABI)-Application
to field‐Inhomogeneity correction of CEST MRI data. Magn Reson
Med 2017, 77: 571-580.